Hormonal Contraceptives Market to be dominated by Combination Hormonal Contraceptives type through 2028
The growth of Global Hormonal Contraceptives in the
forecast period, 2024-2028 is driven by the Increasing awareness about family
planning.
According to TechSci Research report, “Hormonal Contraceptives Market -
Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028”, The
Global Hormonal Contraceptives Market is anticipated to grow at an impressive rate
in the forecast period, 2024-2028. This can be ascribed to the increasing
need for preventing unintended pregnancy along with family planning among the population
across the globe. Additionally, growing health issues associated with teenage
pregnancies, and increasing awareness about modern contraception methods, especially
in the developed countries in North America and Europe are expected to create
lucrative opportunities for market growth in coming years. Besides, the increasing
rising use of oral pills to prevent unplanned pregnancy and rising research and
development activities to develop novel contraceptive pills are further
expected to support the market growth. Also, growing technological advancement
is a key trend for gaining popularity in the hormonal contraceptive market
during the forecast period.
However, the easy
availability of alternatives of contraceptive methods and health risk
associated with the use of contraceptives slow down the growth of the global hormonal
contraceptives market in the forecast period. Similarly, increasing side
effects of using contraceptive pills may hamper the hormonal contraceptive market
growth during the forecast period. Also, a lack of social acceptance with a negative
impact on using contraceptive in emerging countries can further restrict the
growth of the global hormonal contraceptives market.
Browse over XX market data
Figures spread through XX
Pages and an in-depth TOC on "Global Hormonal Contraceptives Market".
Based on Hormone, the global hormonal
contraceptives market can
be divided into Combination Hormonal Contraceptives and Progestin
Only. The combination
hormonal contraceptives segment dominated the market in 2022 and is expected to
continue maintaining its dominance throughout the forecast period. This can be
ascribed to a prominent growth rate along with easy availability of combined
hormonal contraceptives with better efficacy to prevent pregnancy. However, the
growing demand for lower-risk associated contraceptive pills can further propel
the market growth during the forecast period.
Based on method, the market can be segmented Pill, Intrauterine
Device, Injectable, Vaginal Ring, Implant, Others. The contraceptive pill segment is expected to
dominate during the forecast period on account of the simple and easy
administration, of feasibly available products with increasing awareness about
using pills in the market. Similarly, the presence of different major players
in the field and growing penetration in emerging countries are expected to
create significant growth of the global hormonal contraceptive market during
the forecast period. Also, longer action span, effectivity, no effect of the
device on breastfeeding and normal fertility after removal of the devices are
some of the major factors which will boost the growth of the market over the
years.
Major companies operating in the global hormonal contraceptives market are:
- Abbvie, Inc.
- Afaxys, Inc.
- Teva
Pharmaceuticals Industries Ltd.
- Bayer AG
- Merck &
Co. Inc.
- Organon Group
of Companies
- Pfizer Inc.
- Johnson &
Johnson
- Lupin Pharmaceuticals
Inc.
- Pregna
International Ltd.
Recent Development
- In
May 2021, Pantarhei Bioscience made an announcement about the company got the
approval for the new oral contraceptive Estelle from the European Commission
and it can be marketed in all the European States.
- In
April 2021, Mayne Pharma Group Limited and Mithra Pharmaceuticals announced
about the approval by U.S FDA for oral contraceptive named as NEXTSTELLS and it
contains estetrol which is produced from a plant source.
- In
April 2021, The Medicines and Healthcare Products Regulatory Agency launched a
guidelines on COVID-19 Vaccine AstraZeneca unlikely to occur blood clots and it
state that all healthcare providers should provide safe and effective
contraceptive care which includes the combined pill, transdermal patch and
vaginal ring for who is actually at high risk of thrombosis whenever they use
CHS.
Download Free Sample Report
Customers can also request for 10% free customization on this report.
“North
America is expected to dominate in the global hormonal contraceptives market
on account due to the increasing major players in the market and increasing
sexual health awareness among population across the region. Furthermore, increasing
high proportion of unwanted pregnancies, investment by major key players to manufacture
novel contraception devices for females are further contributing to demand for
hormonal contraceptives is expected to create a significant growth during the
forecast period. Similarly, growing focuses on family planning and growing
demand for prevention of unwanted pregnancies and urbanization coupled with
user awareness is further expected to create lucrative opportunities for the
market growth” said Mr. Karan Chechi, Research Director with TechSci Research,
a research based global management consulting firm.
“Hormonal Contraceptives Market - Global Industry
Size, Share, Trends, Opportunity, and Forecast, 2018-2028 Segmented By Method
(Pill, Intrauterine Device, Injectable, Vaginal Ring, Implant, Others), By Hormone
(Combination Hormonal Contraceptives v/s Progestin Only), By Region and
Competition”, has
evaluated the future growth potential of global hormonal contraceptives market
and provides statistics & information on market size, structure, and future
market growth. The report intends to provide cutting-edge market intelligence
and help decision makers take sound investment decisions. Besides, the report
also identifies and analyzes the emerging trends along with essential drivers,
challenges, and opportunities in global hormonal contraceptives market.
Contact
Mr. Ken Mathews
708 Third Avenue,
Manhattan, NY,
New York – 10017
Tel: +1-646-360-1656
Email: [email protected]
Connect with us
on Twitter - https://twitter.com/TechSciResearch
Connect with us
on LinkedIn - https://www.linkedin.com/company/techsci-research